[Cheddar] Abraham Heifets, Co-founder & CEO of Atomwise joins Cheddar to discuss the company’s recent funding round and it’s coronavirus-related projects.
[Drug Target Review] According to a new report, artificial intelligence (AI) is vital for the rapid identification of drugs that can be repurposed to combat COVID-19.
[AiThority] Recently, a news report suggested that a team of AI scientists have made a belligerent effort to identify hundreds of new drugs as a potential COVID-19 therapy. COVID-19 is caused by the novel coronavirus, SAR COV-2, whose origins have been speculated to be a wet market in Wuhan in China. AI engineers and pharmaceutical companies are […]
Drug discovery startup Atomwise and stroke risk predictor Viz.ai are among a group of seven healthcare companies recognized by Forbes for their artificial intelligence capabilities.
As Covid-19 continues to threaten lives and livelihoods around the world, a great emphasis has been put on preventing and treating the disease. However, putting a human drug through the FDA approval process costs hundreds of millions of dollars and takes months, if not years, of clinical trials. What if one of the over 7,800 […]